MedPath

CANCER INTELLIGENCE CARE SYSTEMS, INC.

CANCER INTELLIGENCE CARE SYSTEMS, INC. logo
πŸ‡―πŸ‡΅Japan
Ownership
Subsidiary
Established
2005-12-14
Employees
-
Market Cap
-
Website
http://www.cics.jp

Clinical Trials

4

Active:1
Completed:3

Trial Phases

2 Phases

Phase 1:2
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
2 (66.7%)
Not Applicable
1 (33.3%)

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

Not Applicable
Completed
Conditions
Angiosarcoma
Malignant Melanoma
First Posted Date
2020-03-03
Last Posted Date
2023-02-08
Lead Sponsor
Cancer Intelligence Care Systems, Inc.
Target Recruit Count
10
Registration Number
NCT04293289
Locations
πŸ‡―πŸ‡΅

National Cancer Center Hospital, Chuo Ku, Tokyo, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.